查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000957

約翰氏症診斷市場：依動物種類、檢測類型、通路和最終用戶分類－2026-2032年全球市場預測

Johne's Disease Diagnostics Market by Animal Type, Test Type, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，約翰氏症診斷市場價值將達到 5.4216 億美元，到 2026 年將成長至 6.1949 億美元，到 2032 年將達到 14.5453 億美元，年複合成長率為 15.14%。

主要市場統計數據
基準年 2025 5.4216億美元
預計年份：2026年 6.1949億美元
預測年份 2032 1,454,530,000 美元
複合年成長率 (%) 15.14%

約翰氏症診斷概要：重點介紹當前挑戰、新興技術和動物健康領導者的策略重點

約翰氏症已成為畜牧健康管理中持續且複雜的挑戰，而準確快速的診斷是有效防治策略的關鍵。本文概述了當前情勢，並將診斷需求置於畜群整體健康管理舉措和研究重點的背景下進行分析。此外，本文也強調了生物學、農場層面實踐和檢查室能力之間的相互關係，這些因素共同決定了檢測結果和後續的管理策略。

分子技術的進步、整合的數據工作流程和先進的團隊管理正在帶來變革性的變化，重塑約翰氏症的診斷。

約翰氏症的診斷格局正在經歷一場變革，這主要得益於技術創新、數據驅動的決策流程以及生產者和醫療專業人員不斷變化的期望。分子擴增技術和即時檢測平台縮短了檢測結果的返回時間，提高了感染早期階段的靈敏度，使得以往因診斷延遲而受限的干涉措施得以實施。同時，免疫檢測技術的改進提高了特異性，擴大了血清學篩檢在團體管理計畫中的實際應用。

分析美國關稅措施對約翰氏症診斷的影響，重點在於供應鏈韌性、試劑進口和採購調整。

近期美國政策調整導致的關稅變動對診斷產品的採購和分銷趨勢產生了顯著影響。診斷平台、試劑和專用耗材通常在生產和分銷的多個環節跨境運輸。關稅措施增加了進口設備和一次性試劑的到貨成本，這可能會對採購預算造成壓力，並延緩向下一代檢測技術的升級。

透過動物種類、檢測方法、最終用戶、分銷管道和技術對約翰氏症診斷進行細分，以幫助制定策略。

詳細的細分方法闡明了診斷需求、技術需求和服務提供之間的交集，為產品開發和市場准入提供了切實可行的指南。在考慮動物種類時，檢測策略需要區分牛和小反芻動物。牛的分析進一步細分為牛和牛。由於與生產相關的經濟因素，乳牛牛通常需要更頻繁的監測；而小反芻動物的策略則分為綿羊和山羊，它們的管理和採樣方式有所不同。檢測類型的細分也揭示了操作上的權衡取捨。培養方法仍然是微生物學確診的重要手段，可在各種液體和固體培養基中進行。同時，免疫檢測，例如酶聯免疫吸附試驗（ELISA）（有競爭性ELISA、間接ELISA和夾心ELISA等形式），提供了可擴展的篩檢能力；而PCR方法，包括常規PCR和即時PCR，則可在分子水平上進行確診並提供定量分析。

對美洲、歐洲、中東和非洲以及亞太地區的約翰氏症診斷進行區域概述：說明法規、供應和部署。

區域背景至關重要，因為不同地區的法規環境、生產系統和供應鏈結構差異顯著。在美洲，一體化的供應鏈、大規模的乳牛和肉牛生產體係以及完善的實驗室促進了診斷方法的應用，為高通量免疫檢測和先進的分子檢測創造了機遇，從而支持畜群層面的監測和商業性風險管理。相較之下，歐洲、中東和非洲地區的管理體制和獸醫基礎設施較為分散，因此，標準協調和跨境合作對於提高可靠診斷方法的可近性以及支援區域監測活動至關重要。

企業層面的洞察，包括策略定位、夥伴關係、產品系列以及研發重點，正在塑造約翰氏症診斷領域的競爭格局。

在約翰氏症診斷領域，企業級發展趨勢受到產品系列、策略夥伴關係以及對實際檢驗的重視等因素共同影響。主要企業正優先考慮將診斷效能與服務等級協定、培訓和資料管理工具結合的整合解決方案。診斷試劑生產商、分銷網路和獸醫服務供應商之間的策略夥伴關係，既能擴大市場覆蓋範圍，又能保障品質和供應的連續性。

為產業領導者提供切實可行的建議，以加強診斷方法的採用、供應的韌性、相關人員的合作以及技術的選擇。

產業領導者可以採取一系列切實可行的措施，加快約翰氏症診斷技術在其整個生產系統中的應用和有效性。首先，他們可以透過與獸醫診所、診斷檢查室和農場管理者共同設計檢測方法和通訊協定，使產品開發藍圖保持一致，從而確保其實用性和使用者接受度。其次，他們可以透過採購管道多元化、與區域分銷商建立合作關係以及製定策略性庫存管理政策來增強供應鏈韌性，從而減輕貿易中斷和試劑短缺的影響。第三，他們可以投資於培訓和技術支持，以提高現場檢測的有效性，減少用戶錯誤，並縮短與先進分子診斷相關的學習曲線。

調查方法，包括一級和二級調查方法、資料檢驗程序、相關人員參與和分析框架。

本次高階主管分析的調查方法融合了定性和定量方法，以確保其嚴謹性和有效性。初步研究包括對實驗室經理、獸醫、供應鏈經理和科研人員進行結構化訪談，以了解實際營運、檢驗預期和採購決策標準。除上述相關人員外，研究也盡可能進行現場考察和流程觀察，以便深入了解檢體採集物流、處理能力限制和最終使用者培訓需求。

整合診斷技術進步、營運挑戰和策略路徑，以減輕約翰氏症對整個動物健康系統的影響。

這個結論綜合考慮了診斷技術的進步、營運挑戰以及影響約翰氏症控制工作的策略方法。分子檢測和免疫檢測技術的進步為早期發現感染和實施更精細的人群干預措施提供了重要機會。然而，供應鏈限制、終端用戶能力差異以及監管複雜性等營運障礙可能會阻礙診斷技術的進步轉化為疾病影響的顯著降低。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：約翰氏症診斷市場：依動物類型分類

  • 牛
    • 牛
    • 牛
  • 綿羊/山羊
    • 山羊
    • 羊

第9章：約翰氏症診斷市場－檢測類型

  • 文化
    • 液體培養基
    • 固體培養基培養
  • ELISA
  • PCR
  • 基於定序的檢測
    • 目標序列面板
    • 全基因組定序

第10章：約翰氏症診斷市場：依分銷管道分類

  • 直銷
  • 銷售代理
  • 線上

第11章：約翰氏症診斷市場：以最終用戶分類

  • 診斷檢查室
    • 醫院檢查室
    • 獨立檢測實驗室
  • 農場
    • 養殖場
    • 酪農
  • 研究機構
  • 動物醫院

第12章：約翰氏症診斷市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：約翰氏症診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：約翰氏症診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國瓊氏症診斷市場

第16章：中國約翰氏症診斷市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • HiMedia Laboratories
  • IDEXX Laboratories, Inc.
  • IDvet
  • INDICAL BIOSCIENCE GmbH
  • Merck Animal Health
  • MV Diagnostics
  • Neogen Corporation
  • PBD Biotech Ltd.
  • Pictor Diagnostics
  • Promega Corporation
  • QIAGEN NV
  • Randox Laboratories
  • Tetracore, Inc.
  • Thermo Fisher Scientific Inc.
  • VMRD, Inc.
  • Zoetis Inc.
Product Code: MRR-0D217D5AD843

The Johne's Disease Diagnostics Market was valued at USD 542.16 million in 2025 and is projected to grow to USD 619.49 million in 2026, with a CAGR of 15.14%, reaching USD 1,454.53 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 542.16 million
Estimated Year [2026] USD 619.49 million
Forecast Year [2032] USD 1,454.53 million
CAGR (%) 15.14%

Executive overview of Johne's disease diagnostics highlighting current challenges, emerging technologies, and strategic priorities for animal health leaders

Johne's disease has emerged as a persistent and complex challenge for livestock health management, with diagnostic fidelity and timeliness at the center of effective control strategies. This executive introduction sets the scene by contextualizing diagnostic needs within herd health initiatives and research priorities. It emphasizes the intersection of biology, farm-level practices, and laboratory capabilities that together determine detection outcomes and downstream management choices.

To move from recognition to action, stakeholders require clarity about diagnostic modalities, their respective performance characteristics, and how test selection interfaces with herd type and production objectives. Advances in molecular and immunological methods have introduced new opportunities, yet they coexist with legacy approaches that retain relevance depending on clinical stage and operational constraints. Consequently, diagnostic pathways must be defined with attention to animal type, specimen logistics, and the practicalities of sampling and result interpretation.

Transitioning from tactical testing to strategic surveillance demands a common framework that aligns laboratory capacity, end-user needs, and technology adoption. This introduction outlines that framework, framing diagnostic considerations as essential inputs to broader disease mitigation, biosecurity protocols, and value-chain resilience. It also underlines the need for evidence-based decision-making that harmonizes scientific rigor with the realities of field deployment and commercial animal production.

Transformative shifts reshaping Johne's disease diagnostics driven by molecular advances, integrated data workflows, and progressive herd management

The diagnostics landscape for Johne's disease is being transformed by convergence of technological innovation, data-enabled decision processes, and evolving expectations from producers and health professionals. Molecular amplification techniques and real-time detection platforms have compressed turnaround times and enhanced sensitivity in earlier stages of infection, thereby enabling interventions that were previously constrained by diagnostic latency. At the same time, improvements in immunoassay formats have refined specificity and broadened the practical utility of serological screening in herd management programs.

Concurrently, digital integration and laboratory information management systems are enabling more coherent data flows between diagnostic providers and farm operators. These integrated workflows support trend analysis, risk stratification, and targeted testing strategies that reduce unnecessary sampling while increasing the yield of diagnostically actionable information. Moreover, cross-sector collaboration between veterinary clinics, research institutions, and diagnostic laboratories is fostering validation studies and real-world evidence generation that accelerate adoption of best practices.

As these shifts take effect, operational models are also changing. On-farm sampling protocols, cold chain logistics, and remote consultation services are evolving to support broader accessibility of advanced tests. The combined effect of technological maturation and operational innovation is to make precision surveillance more attainable across production systems, provided that stakeholders address barriers related to cost, training, and regulatory harmonization.

Impact analysis of United States tariff actions on Johne's disease diagnostics, focusing on supply chain resilience, reagent imports, and procurement adjustments

Recent tariff adjustments originating from United States policy have exerted a discernible influence on the procurement and distribution dynamics of diagnostics-related goods. Diagnostic platforms, reagents, and specialty consumables commonly cross international borders during multiple stages of production and distribution. Tariff measures increase the landed cost of imported instruments and single-use reagents, which in turn exerts pressure on procurement budgets and can delay upgrades to next-generation assays.

These trade-related pressures also reverberate across supply chains, incentivizing localized sourcing but potentially limiting access to specialized reagents that remain concentrated among a limited set of global suppliers. Consequently, laboratories and clinics may face temporary capacity constraints, longer lead times, and a need to diversify suppliers. In response, many organizations are revisiting inventory policies, negotiating longer-term contracts, and evaluating kit substitution strategies to preserve continuity of diagnostic services.

Beyond immediate cost and availability effects, tariff changes have accelerated conversations about supply chain resilience and strategic sourcing. Stakeholders are increasingly evaluating alternative distribution models, regional partnerships, and localized manufacturing as mitigants. Policymakers and industry leaders should therefore consider coordinated responses that balance trade policy objectives with the operational realities of veterinary diagnostics to ensure sustained access to the tools necessary for effective disease control.

Segmentation insights for Johne's disease diagnostics across animal types, test methods, end users, distribution channels, and technologies to inform strategy

A nuanced segmentation approach clarifies where diagnostic demand, technical needs, and service delivery converge, offering actionable guidance for product development and market engagement. When considering animal type, testing strategies must differentiate between cattle and small ruminants; cattle analysis further distinguishes beef cattle and dairy cattle, with dairy herds often requiring more frequent surveillance due to production-linked economic drivers, while small ruminant strategies divide into sheep and goats with distinct management and sampling profiles. Test type segmentation likewise informs operational trade-offs: culture methods retain value for definitive microbial confirmation and are practiced in liquid media culture and solid media culture variants, whereas immunoassays such as ELISA-available in competitive ELISA, indirect ELISA, and sandwich ELISA formats-offer scalable screening capabilities, and PCR modalities including conventional PCR and real-time PCR deliver molecular confirmation and quantitative insights.

End-user segmentation underscores the differing needs and decision frameworks of diagnostic labs, farms, research institutes, and veterinary clinics. Diagnostic labs include hospital labs and independent labs, each with specific throughput and accreditation considerations; farms encompass breeding farms and dairy farms that vary in testing frequency and biosecurity practices; veterinary clinics range from independent clinics to large clinics with integrated services, while research institutes tend to focus on assay validation and longitudinal studies. Distribution channel segmentation reveals opportunities for direct sales, distributor partnerships, and online procurement, with distributors categorized as national distributors or regional distributors depending on scale and reach. Finally, technology segmentation highlights DNA-based modalities such as LAMP, PCR, and qPCR, immunoassay approaches including agar gel immunodiffusion and ELISA, and microbial culture options across liquid media and solid media platforms.

Synthesizing these segmented dimensions enables targeted product positioning and tailored commercial strategies. For instance, rapid molecular assays map well to diagnostic labs and large clinics with demand for confirmatory testing, while scalable ELISA formats align with high-volume screening needs on dairy farms and breeding operations. Understanding the interplay of animal type, test characteristics, end-user capabilities, distribution channels, and enabling technologies allows stakeholders to prioritize investments and craft differentiated value propositions.

Regional overview of Johne's disease diagnostics spanning Americas, Europe Middle East & Africa, and Asia-Pacific highlighting regulatory, supply, and adoption

Regional context matters because regulatory environments, production systems, and supply chain architectures vary substantially across geographies. In the Americas, diagnostic adoption is influenced by integrated supply chains, large-scale dairy and beef operations, and established laboratory networks, creating opportunities for high-throughput immunoassays and advanced molecular testing that support herd-level surveillance and commercial risk management. By contrast, Europe, Middle East & Africa presents a patchwork of regulatory regimes and veterinary infrastructures where harmonized standards and cross-border collaboration are key to improving access to reliable diagnostics and to supporting regional surveillance initiatives.

Asia-Pacific encompasses diverse production systems, from smallholder operations to intensive commercial farms, and has experienced rapid uptake of point-of-care and molecular testing in response to growing demand for traceability and productivity. Across all three regions, logistical considerations such as cold chain reliability, reagent import pathways, and the geographic distribution of accredited laboratories shape which diagnostic solutions are practical. Moreover, regional differences in regulatory approval timelines, lab accreditation processes, and reimbursement or subsidy frameworks influence the speed at which novel assays become operationally viable.

Taken together, regional insights suggest that successful commercial strategies must align technology deployment with local regulatory expectations, distribution realities, and end-user capabilities. Stakeholders should therefore calibrate product design, service models, and engagement approaches to the specific characteristics of the Americas, Europe Middle East & Africa, and Asia-Pacific markets to maximize uptake and operational impact.

Company-level insights into strategic positioning, partnerships, product portfolios, and R&D focus shaping the Johne's disease diagnostics competitive landscape

Company-level dynamics in Johne's disease diagnostics are shaped by the interplay of product portfolios, strategic partnerships, and an emphasis on validation under real-world conditions. Leading organizations prioritize integrated solutions that combine assay performance with service-level agreements, training, and data management tools. Strategic partnerships between diagnostic manufacturers, distribution networks, and veterinary service providers enable broader market reach while supporting quality assurance and continuity of supply.

Investment in R&D remains central to differentiation, with companies focusing on enhancing sensitivity and specificity, reducing time-to-result, and designing assays that perform robustly across specimen types and stages of infection. Meanwhile, competitive positioning often hinges on the ability to offer scalable options-from high-throughput ELISA platforms suited for herd screening to compact molecular systems designed for decentralized testing. Commercial strategies also reflect an increasing emphasis on lifecycle support, including technical training for end users, structured validation programs, and post-market performance monitoring.

Corporate initiatives that prioritize regulatory alignment, supply chain resilience, and customer-centric service offerings are more likely to achieve sustained adoption. As a result, market leaders are those that integrate technological innovation with pragmatic go-to-market models, enabling veterinary professionals and producers to convert diagnostic information into timely, actionable interventions.

Actionable recommendations for industry leaders to strengthen diagnostics adoption, supply resilience, stakeholder collaboration, and technology choices

Industry leaders can pursue a sequence of pragmatic actions to accelerate the adoption and impact of Johne's disease diagnostics across production systems. First, align product development roadmaps with end-user workflows by co-designing assays and operating protocols with veterinary clinics, diagnostic laboratories, and farm managers to ensure practical fit and user acceptance. Second, strengthen supply chain resilience through diversified sourcing, regional distributor partnerships, and strategic inventory policies that mitigate exposure to trade disruptions and reagent shortages. Third, invest in training and technical support to raise the effective performance of assays in field conditions, reduce user errors, and shorten the learning curve associated with advanced molecular methods.

Additionally, leaders should prioritize data interoperability by adopting standardized reporting formats and laboratory information systems that enable timely data sharing and trend analysis. This enhances surveillance capabilities and supports evidence-based interventions. Collaborations with research institutes can accelerate independent validation and foster real-world evidence generation that underpins broader adoption. Finally, stakeholders should engage proactively with regulatory authorities to streamline approval pathways and to clarify performance expectations for emerging diagnostics. By implementing these recommendations, organizations will improve diagnostic accessibility, enhance the quality of surveillance, and increase the overall efficacy of disease control programs.

Research methodology detailing primary and secondary research approaches, data validation procedures, stakeholder engagement, and analytical frameworks

The research methodology underpinning this executive analysis integrates qualitative and quantitative approaches to ensure rigor and relevance. Primary research comprised structured interviews with laboratory directors, veterinary practitioners, supply chain managers, and research scientists to capture operational realities, validation expectations, and procurement decision criteria. These stakeholder conversations were supplemented by site visits and process observations where feasible, allowing for a grounded appreciation of sampling logistics, throughput constraints, and end-user training needs.

Secondary research involved a systematic review of peer-reviewed literature, technical white papers, and regulatory guidance to triangulate performance claims and to contextualize technological trends. Data validation protocols were implemented to cross-check supplier specifications against independent validation studies and field performance reports. Analytical frameworks employed causal mapping and decision-tree analysis to translate technical attributes into practical implications for different end-user types and regional contexts.

Throughout, transparency in assumptions and a focus on reproducibility guided the research design. Where uncertainty exists, the methodology emphasizes evidence weighting and sensitivity analysis to distinguish well-supported findings from areas requiring further validation. This approach ensures that the insights presented are robust, actionable, and aligned with the needs of decision-makers involved in Johne's disease diagnostics.

Conclusion synthesizing diagnostic advances, operational challenges, and strategic pathways to reduce Johne's disease impact across animal health systems

This conclusion synthesizes the diagnostic advances, operational challenges, and strategic pathways that collectively shape efforts to control Johne's disease. Technological progress in molecular assays and refined immunoassays offers meaningful opportunities to detect infection earlier and to deploy more nuanced herd-level interventions. Yet, operational obstacles-such as supply chain constraints, variable end-user capacity, and regulatory complexity-can impede the translation of diagnostic improvements into measurable reductions in disease impact.

To bridge this gap, coordinated action is necessary: technology providers must align product design with the realities of end-user workflows; distribution networks should pursue resilience and responsiveness; and regulatory stakeholders must collaborate to clarify pathways that incentivize rigorous validation without imposing undue barriers. In parallel, investment in training and data infrastructure will enhance the effective use of diagnostics, enabling stakeholders to convert test results into timely management decisions.

Ultimately, the pathway to sustained improvement rests on the integration of scientific innovation with pragmatic operational planning. By prioritizing interoperability, evidence-based validation, and stakeholder collaboration, the industry can enhance the role of diagnostics in reducing disease burden and in supporting more resilient animal health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Johne's Disease Diagnostics Market, by Animal Type

  • 8.1. Cattle
    • 8.1.1. Beef Cattle
    • 8.1.2. Dairy Cattle
  • 8.2. Sheep & Goats
    • 8.2.1. Goats
    • 8.2.2. Sheep

9. Johne's Disease Diagnostics Market, by Test Type

  • 9.1. Culture
    • 9.1.1. Liquid Media Culture
    • 9.1.2. Solid Media Culture
  • 9.2. ELISA
  • 9.3. PCR
  • 9.4. Sequencing-Based Assays
    • 9.4.1. Targeted Sequencing Panels
    • 9.4.2. Whole-Genome Sequencing

10. Johne's Disease Diagnostics Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors
  • 10.3. Online

11. Johne's Disease Diagnostics Market, by End User

  • 11.1. Diagnostic Labs
    • 11.1.1. Hospital Labs
    • 11.1.2. Independent Labs
  • 11.2. Farms
    • 11.2.1. Breeding Farms
    • 11.2.2. Dairy Farms
  • 11.3. Research Institutes
  • 11.4. Veterinary Clinics

12. Johne's Disease Diagnostics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Johne's Disease Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Johne's Disease Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Johne's Disease Diagnostics Market

16. China Johne's Disease Diagnostics Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. bioMerieux SA
  • 17.7. HiMedia Laboratories
  • 17.8. IDEXX Laboratories, Inc.
  • 17.9. IDvet
  • 17.10. INDICAL BIOSCIENCE GmbH
  • 17.11. Merck Animal Health
  • 17.12. MV Diagnostics
  • 17.13. Neogen Corporation
  • 17.14. PBD Biotech Ltd.
  • 17.15. Pictor Diagnostics
  • 17.16. Promega Corporation
  • 17.17. QIAGEN N.V.
  • 17.18. Randox Laboratories
  • 17.19. Tetracore, Inc.
  • 17.20. Thermo Fisher Scientific Inc.
  • 17.21. VMRD, Inc.
  • 17.22. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)